Cdc25A has also been shown to be overexpressed in other cancer types, including high-grade serous ovarian cancer and head-and-neck squamous cell carcinoma31,38, which are characterized by genomic instability39,40. This evidence concerns the gene CDC25A and ovarian serous adenocarcinoma.